Short-Course Antiretroviral Therapy in Primary HIV Infection | Zendy

Sarah Fidler | Zendy; Kholoud Porter | Zendy; Fiona M Ewings | Zendy; John Frater | Zendy; Gita Ramjee | Zendy; David A. Cooper | Zendy; Helen Rees | Zendy; Martin Fisher | Zendy; Mauro Schechter | Zendy; Pontiano Kaleebu | Zendy; Giuseppe Tambussi | Zendy; S Kinloch | Zendy; José M. Miró | Zendy; Anthony D. Kelleher | Zendy; Myra O. McClure | Zendy; Steve Kaye | Zendy; Michelle M. Gabriel | Zendy; Rodney Phillips | Zendy; Jonathan Weber | Zendy; Abdel Babiker | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Short-Course Antiretroviral Therapy in Primary HIV Infection

Author(s) -

Sarah Fidler,

Kholoud Porter,

Fiona M Ewings,

John Frater,

Gita Ramjee,

David A. Cooper,

Helen Rees,

Martin Fisher,

Mauro Schechter,

Pontiano Kaleebu,

Giuseppe Tambussi,

S Kinloch,

José M. Miró,

Anthony D. Kelleher,

Myra O. McClure,

Steve Kaye,

Michelle M. Gabriel,

Rodney Phillips,

Jonathan Weber,

Abdel Babiker

Publication year - 2013

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1110039

Subject(s) - medicine , confidence interval , antiretroviral therapy , hazard ratio , seroconversion , human immunodeficiency virus (hiv) , pediatrics , viral load , immunology

Short-course antiretroviral therapy (ART) in primary human immunodeficiency virus (HIV) infection may delay disease progression but has not been adequately evaluated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research